(24/7 Market News) Janone Inc (NASDAQ: JAN) is running again, trading at $4.41, 63 cents higher (+16.66%), on 7.24 million shares traded, but well off its early session high of $4.77.
Shares in the company, which is focused on the development of drugs with non-addictive, pain-relieving properties, have been trading higher since its stated, two days ago, that it was issued a patent that covers a method of improving nerve function using JAN101, a potential treatment for peripheral artery disease (PAD), a vascular disease that affects more than 8.5 million people in the U.S. and more than 60 million people worldwide.
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.